Neothetics Priced, Nasdaq: NEOT

Developing an injectable version of an approved asthma drug to reduce belly fat.

Industry: Health Care

Latest Trade: $1.39 -0.05 (-3.1%)

First Day Return: -14.3%

Return from IPO: -89.8%

Industry: Health Care

Developing an injectable version of an approved asthma drug to reduce belly fat.
more less
IPO News for Neothetics
more
IPO Data
IPO File Date 10/17/2014
Offer Price $14.00
Price Range $13.00 - $15.00
Offer Shares (mm) 4.7
Deal Size ($mm) $65
IPO Data
IPO Date 11/19/2014
Offer Price $14.00
Price Range $13.00 - $15.00
Offer Shares (mm) 4.7
Deal Size ($mm) $65
Underwriters
more
Company Data
Headquarters San Diego, CA
Founded 2007
Employees 9
Website www.neothetics.com